m6A-Related Regulation of Ferroptosis Contributes to Nasal Epithelial Barrier Dysfunction in Allergic Rhinitis

Zehua Lin1, Baoai Han1, Qiang Xie1

  • 1Department of Otorhinolaryngology Head and Neck Surgery, Zhongnan Hospital of Wuhan University, Wuhan, China.

Allergy
|August 10, 2026
PubMed
Abstract

Insights

House dust mite exposure triggers ferroptosis, a cell death pathway, leading to nasal epithelial barrier damage in allergic rhinitis. This damage is mediated by GAS1 suppressing GPX4, a process regulated by m6A methylation.

Area of Science:

  • Immunology
  • Cell Biology
  • Molecular Biology

Background:

  • Ferroptosis, a cell death form driven by lipid peroxidation, is implicated in respiratory injury but its role in allergic rhinitis (AR) is unknown.
  • Investigating ferroptosis in AR is crucial for understanding disease pathogenesis.

Purpose of the Study:

  • To assess the role of ferroptosis in allergic rhinitis (AR) pathogenesis.
  • To elucidate the molecular mechanisms underlying ferroptosis in AR.

Main Methods:

  • Utilized human nasal epithelial cells and mouse models to study house dust mite (HDM)-induced ferroptosis and barrier disruption.
  • Employed m6A assays, RIP-qPCR, and MeRIP-qPCR to analyze N6-methyladenosine (m6A) methylation and its regulatory role.
  • Validated findings using clinical nasal mucosal samples and GAS1-knockdown mice.

Main Results:

  • HDM exposure induced ferroptosis and epithelial barrier disruption, characterized by increased lipid peroxidation.
  • Glutathione peroxidase 4 (GPX4) protected against ferroptosis; its inhibition or knockdown exacerbated epithelial damage.
  • Growth arrest-specific 1 (GAS1) promoted ferroptosis by downregulating GPX4, a mechanism confirmed in vivo.
  • GAS1's effect on GPX4 was mediated by METTL3-dependent m6A modification of GPX4 mRNA.

Conclusions:

  • HDM exposure drives AR pathogenesis via ferroptosis-induced nasal epithelial barrier impairment.
  • GAS1-METTL3-mediated regulation of GPX4 m6A methylation represents a novel mechanism in AR.
  • Targeting this pathway may offer therapeutic strategies for allergic rhinitis.